ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

BGM vs FHTX // EV/EBITDA & P/E VALUATION

BGM Group Ltd. (Class A) (NASDAQ) VS. Foghorn Therapeutics Inc. (NASDAQ) • 15-METRIC TALLY: BGM 5 — FHTX 1
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (BGM VS. FHTX) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC BGM FHTX SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 16.60% — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) — -35.00% — TIE /roic <GO>
EV/EBITDA & P/E Valuation ACTIVE — — — TIE /valuation <GO>
Free Cash Flow Yield -3.09% — — TIE /fcf-yield <GO>
Operating Margin -33.20% -60.00% +26.80 BGM /operating-margins <GO>
Net Profit Margin -52.60% -60.00% +7.40 BGM /net-margins <GO>
Revenue Growth (YoY) 51.10% 36.80% +14.30 BGM /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — 0.20 — TIE /balance-sheet <GO>
Piotroski F-Score Quality 2/9 3/9 -1.00 FHTX /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 56.6 30.4 +26.21 BGM /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $127.4M $124.1M $3.3M BGM /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR BGM REV FHTX REV BGM GROSS % FHTX GROSS % BGM FCF FHTX FCF
FY 2025 $37.9M $30.9M 16.6% — -$3.9M -$86.1M
FY 2024 $25.1M $22.6M 16.4% — $304.1K -$101.3M
FY 2023 $46.5M $34.2M — — $312.2K -$118.1M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
BGM // BETA —
FHTX // BETA —